scorecardresearch
Add as a preferred source on Google
Sunday, September 13, 2026
Celebrating 9 Years
Support Our Journalism

Support our Journalism

9th Anniversary: Free Tote & Mug

Subscribe
TopicPharma

Topic: Pharma

Trump takes aim at branded pharma products with 100% tariff, unclear on generic drugs for now

The new tariffs, effective 1 October, are also aimed at kitchen cabinets, bathroom vanities & heavy trucks. Any levies on generic drugs could be a blow to Indian pharma exports to the US.

India has a substandard, fake drugs problem. Lack of recall law, scrutiny is making matters worse

Underlining need for more accountability, experts also stress that govt data does not include fixed dose combination drugs, which account for over 40% of drugs sold in India.

Panel will keep watch for violation of new drug marketing code, says pharma secretary

Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.

Govt move to review drug pricing mechanism triggers concern as pharma industry invited to join panel

Panel formed by Centre to review pricing framework for drugs & medical devices will have representatives from Indian Pharmaceutical Alliance & Indian Drug Manufacturers Association.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

‘Diabetes capital’ India slated to get world’s 1st once-a-week insulin ‘by 2025’

Danish pharma giant Novo Nordisk's Icodec could be game-changer for diabetics. The drug is nearing regulatory approval in US & EU, says company.

Govt sets deadline for pharma MSMEs to adopt good manufacturing practices. ‘Follow or be penalised’

Health minister concedes implementation of Schedule M of Drugs and Cosmetics Act has been poor. Timeline for adherence to norms for good manufacturing practices began on 1 August.

Special inspection drive by drug controllers in 20 states, 26 pharma companies show-caused

The Drug Controller General of India (DCGI) has carried out nationwide inspections following a spate of incidents where drugs imported from India were found to be substandard or spurious.

Meth manufacturing drugs worth Rs 390 cr seized in Mizoram, probe suggests trafficking to Myanmar

Assam Rifles and the Mizoram customs department seized 39,04,000 triprolidine and pseudoephedrine tablets which act as precursors in manufacturing of addictive crystal methamphetamine.

On Camera

Srinagar’s cinemas may have gone dark. Kashmir’s love for films never did

It seemed like J&K's battered past had taken a backseat, even if it was for the four days of the international film festival.

Global funds sour on India stocks as some cut allocation to zero

Weak corporate earnings and the lack of an AI investment theme are prompting global investors to cut India exposure.

‘Society as battlefield’: NATO cites Indian military paper on cognitive warfare. What it says

In a seminal work, former military officers Lt. Gen. D.S. Hooda & Lt. Col. Pavithran Rajan put forth a framework to approach cognitive warfare, called Socio-Technical-Cognitive Battlespace.

The real BRICS story is what China, Russia want & India wishes

India, China and Russia share more contradictions than congruence. Each has a different worldview, as also a different adversary. The rude fact is that BRICS is the most irrelevant of all such groupings.